NAMI Oregon Oregon
 
  Welcome
  Annual Conference
  Education
  Upcoming Trainings
  Advocacy
  Membership
  Affiliates
  NAMIWalks Northwest
  Latest Research from NIMH
   NIMH Archives
  Newsroom
  Support


from NAMI.org
Join NAMI Today Keep up with NAMI news stories, events and blogs, connect with your affiliate and bring support and hope to others.
Register for the 2015 NAMI National Convention in San Francisco
Find a Discussion Groups
Top News Stories
Find more at NAMI.org
stars graphic

 

 | Print this page | 

National Institute of Mental Health (NIMH)
Outreach Partnership Program

The National Institute of Mental Health of the National Institutes of Health is the lead Federal agency for research on mental and behavioral disorders. NIMH envisions a world in which mental illnesses are prevented and cured. The mission of NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery, and cure. This public health mandate demands that the Institute harness powerful scientific tools to achieve better understanding, treatment, and eventually, prevention of these disabling conditions that affect millions of Americans.

The Outreach Partnership Program is a nationwide initiative of the National Institute of Mental Healths (NIMH) Office of Constituency Relations and Public Liaison (OCRPL). The Program works to increase the publics access to science-based mental health information through partnerships with national and state nonprofit organizations. The Program has a particular emphasis on reaching historically underserved populations. The Program also strives to enhance opportunities for the public to benefit from participation in research. These partnerships provide NIMH with the opportunity to engage community organizations in dialogue to better understand the needs, questions, and concerns of those intended to benefit from the research the Institute supports.

Objectives
The Outreach Partnership Program is vital to NIMHs efforts to deliver science-based information to communities across the country. Specifically, the Program is designed to:

  • Foster more widespread understanding about mental disorders, the brain, and behavior, thereby helping to reduce misperceptions and negative attitudes towards mental illness;
  • Increase awareness of the role of basic, translational, and clinical research in the understanding, prevention, and treatment of mental illnesses; and
  • Increase awareness about the opportunities to benefit from participation in mental health research.

Outreach Partners
There are 55 Outreach Partner organizations representing all states, the District of Columbia, and Puerto Rico. Outreach Partners disseminate NIMH research findings and educational materials to the public throughout their states and local communities, including families and individuals affected by mental illness, healthcare professionals, underserved populations, and other constituencies such as schools, social service agencies, and faith-based organizations. Outreach Partners also conduct targeted outreach activities to address mental disorders among children and adolescents and other populations identified to be at-risk, and mental health disparities that occur because of race, ethnicity, age (e.g., older adults), education, income, disability status, geographic location, or risk status related to sex and gender. In addition, Outreach Partners promote volunteer participation in NIMH and NIH clinical trials and often collaborate with researchers to advance the research process. Learn more about what Outreach Partners are doing to address mental health disparities and increase awareness about mental disorders during childhood and adolescence.

Outreach Partners are selected through a competitive process and serve three-year terms. Benefits provided to these organizations include an annual stipend, sponsored participation in an annual meeting, the biweekly electronic Update newsletter featuring the latest Federal news and resources related to mental health, and access to NIMH scientific and educational publications for mass dissemination. Partners are able to network among themselves and with Federal, national, and state organizations through the annual meetings and a dedicated electronic mailing list.
See list of Outreach Partners

NAMI Oregon is proud to serve as an NIMH Outreach Partner. We welcome the opportunity to continue providing Oregonians affected by mental illness with the latest science-based mental health information. Please see notices of clinical trial recruitment and read about the latest developments in NIMH's pursuit of its mission below (click on the update title to read the full text).

Notices of Clinical Trial Recruitment

For general information on clinical trials, browse the respective webpages for NIMH Clinical Trials and NIH Clinical Trials. Also see the NIMH Join a Mental Health Research Study webpage and the NIH Learn about Clinical Studies webpage.

July 1, 2015

NATIONWIDE RECRUITMENT: BIPOLAR DISORDER (PEDIATRIC) RESEARCH STUDY TREATMENT OF SEVERE MOOD DYSREGULATION

(Inpatient: 12- to 15 weeks) This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy and not currently hospitalized, psychotic or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]
http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/childrens-studies/citalopram-methylphenidate-bpd.shtml

For more information on research conducted by the National Institute of Mental Health in Bethesda, MD click here www.nimh.nih.gov/JoinAStudy.

June 1, 2015

NATIONWIDE RECRUITMENT: BIPOLAR DISORDER PEDIATRIC RESEARCH STUDY

TREATMENT OF SEVERE MOOD DYSREGULATION

(Inpatient: 12- to 15 weeks) This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy and not currently hospitalized, psychotic, or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]
http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/childrens-studies/citalopram-methylphenidate-bpd.shtml

For more information on research conducted by NIMH in Bethesda, MD click here www.nimh.nih.gov/JoinAStudy.

DISABILITY.GOV BLOG POST: MAKING A DIFFERENCE THROUGH RESEARCH PARTICIPATION

This Disability.gov blog post describes the need for participation in research to advance the diagnosis, treatment, and lives for those with traumatic brain injury. The author is a Research Coordinator with the Center for Neuroscience and Regenerative Medicine, a federal intramural program established through Congressional legislation, designed to foster collaborative research efforts between the Uniformed Services Health and Sciences University, NIH, and Walter Reed National Military Medical Center.
https://usodep.blogs.govdelivery.com/2015/05/26/making-a-difference-through-research-participation/

May 1, 2015

NATIONWIDE RECRUITMENT

BIPOLAR DISORDER (PEDIATRIC) RESEARCH STUDY: TREATMENT OF SEVERE MOOD DYSREGULATION (INPATIENT: 12- TO 15 WEEKS)

This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy and not currently hospitalized, psychotic, or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]
http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/childrens-studies/citalopram-methylphenidate-bpd.shtml

For more information on research conducted by the National Institute of Mental Health in Bethesda, MD click here www.nimh.nih.gov/JoinAStudy.

April 1, 2015

NIH NEWS IN HEALTH: BE A PARTNER IN CLINICAL RESEARCH: HELP OTHERS, HELP YOURSELF

Clinical research, also known as clinical studies or clinical trials, offers hope for many people because it helps to find better treatments. Clinical trials are at the heart of all medical advances. Clinical research occurs at places such as hospitals, universities, doctors' offices, and community clinics. Studies may be funded by foundations, medical institutions, pharmaceutical companies, and federal agencies such as NIH. This NIH article describes the role that volunteer participation, including healthy volunteers, plays in clinical research, as well as issues to consider prior to participating in research.
http://newsinhealth.nih.gov/issue/mar2015/Feature1

NIH BIPOLAR DEPRESSION RESEARCH STUDIES ENROLLING PARTICIPANTS

Call about eligibility to participate in depression research studies.

IS YOUR DEPRESSION/BIPOLAR DEPRESSION HARD TO TREAT?

Experiencing thoughts of sadness, hopelessness, guilt, worthlessness, lacking interest in everyday activities you once enjoyed?

NIH researchers seek seek depressed persons between the ages of 18-65, or people between the ages of 18-70 with bipolar disorder and are currently in a depressive phase, for participation in several brain imaging and medication studies that are evaluating how experimental medications (i.e., ketamine, riluzole and scopolamine) may reduce symptoms rapidly. Participation includes one to four visits, psychiatric interviews, medical history, physical exam, and blood and other medical tests. Some studies are conducted on an outpatient basis, others on an inpatient basis. Participants must be free of other serious medical conditions. Research evaluations and medications are provided at no cost.

The studies are conducted at the NIH Clinical Center in Bethesda, Maryland. There is no cost to participate. We enroll eligible participants locally and from around the country. Travel arrangements are provided and costs covered by NIMH. (Arrangements vary by distance and by specific study.) After completing the study participants receive short-term follow-up care while transitioning back to a provider. Atendemos pacientes de habla hispana.

First Steps to Participate in Research:

  • Call NIMH
  • Learn Study Details
  • Be Evaluated for Eligibility
  • Consent to Participate
Call: 1-877-MIND-NIH (1-877-646-3644)

TTY: 1-866-411-1010
E-mail: moodresearch@mail.nih.gov
http://www.nimh.nih.gov/labs-at-nimh/join-a-study/adults/adults-depression.shtml

For a flyer regarding NIH research studies, click here.

For more information on research conducted by NIMH in Bethesda, MD click here www.nimh.nih.gov/JoinAStudy.

Department of Health and Human Services, NIH, NIMH, Protocol # 01-M-0254

March 1, 2015

NATIONWIDE RECRUITMENT: BIPOLAR DISORDER, PEDIATRIC RESEARCH STUDY

TREATMENT OF SEVERE MOOD DYSREGULATION (SMD)

(Inpatient: 12- to 15 weeks) This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy and not currently hospitalized, psychotic or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]
http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/childrens-studies/citalopram-methylphenidate-irritability.shtml

For more information on research conducted by NIMH in Bethesda, MD click here www.nimh.nih.gov/JoinAStudy.

February 1, 2015

NATIONWIDE RECRUITMENT: NIH BIPOLAR DEPRESSION RESEARCH STUDIES ENROLLING PARTICIPANTS
Call about eligibility to participate in depression research studies.

IS YOUR BIPOLAR DEPRESSION HARD TO TREAT?

EXPERIENCING THOUGHTS OF SADNESS, HOPELESSNESS, GUILT, WORTHLESSNESS, LACKING INTEREST IN EVERYDAY ACTIVITIES YOU ONCE ENJOYED?

NIH researchers seek people between the ages of 18 and 70 with bipolar disorder, who are currently in a depressive phase, for participation in several brain imaging and medication studies that are evaluating how experimental medications (ketamine, riluzole, and scopolamine) may reduce symptoms rapidly. Participation includes one to four visits to the NIH Clinical Center in Bethesda, MD, psychiatric interviews, medical history, physical exam, and blood and other medical tests. Some studies are conducted on an outpatient basis, others on an inpatient basis. Participants must be free of other serious medical conditions. Research evaluations and medications are provided at no cost.

There is no cost to participate in the studies. NIMH enrolls eligible participants locally and from around the country. Travel arrangements are provided and costs covered by NIMH. (Arrangements vary by distance and by specific study.) After completing the study, participants receive short-term follow-up care while transitioning back to a provider in their community.

Atendemos pacientes de habla hispana.

FIRST STEPS TO PARTICIPATE IN RESEARCH:

  • Call NIMH
  • Learn Study Details
  • Be Evaluated for Eligibility
  • Consent to Participate

Call: 1-877-MIND-NIH (1-877-646-3644)

TTY: 1-866-411-1010
E-mail: moodresearch@mail.nih.gov
Click here for more information

For more information on research conducted by NIMH in Bethesda, MD click here: http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/childrens-studies/citalopram-methylphenidate-irritability.shtml

January 15, 2015

NATIONWIDE RECRUITMENT: BIPOLAR DISORDER (PEDIATRIC) RESEARCH STUDY
TREATMENT OF SEVERE MOOD DYSREGULATION

(Inpatient: 12- to 15 weeks) This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy and not currently hospitalized, psychotic, or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]

For more information on research conducted by NIMH in Bethesda, MD click here: http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/childrens-studies/citalopram-methylphenidate-irritability.shtml

December 1, 2014

NATIONWIDE RECRUITMENT: NIMH ADULT DEPRESSION RESEARCH STUDY
IS YOUR MAJOR DEPRESSION HARD TO TREAT?

This inpatient study is enrolling eligible participants to assess the effectiveness of the oral medication diazoxide versus placebo to rapidly improve hard-to-treat depressive symptoms. Eligibility criteria include people ages 18-65, who are diagnosed with Major Depressive Disorder (MDD), have previously failed to respond to treatment, and who are free of other serious medical conditions. This study can last up to 12 weeks and is conducted at the NIH Clinical Center in Bethesda, Maryland.

There is no cost to participate. NIMH enrolls eligible participants locally and from around the country. Travel arrangements are provided and costs are covered by NIMH (arrangements vary by distance). After completing the study, participants receive short-term follow-up care at the NIH while transitioning back to a provider.
For more information, call: 1-877-MIND-NIH (1-877-646-3644),TTY: 1-866-411-1010, or e-mail: moodresearch@mail.nih.gov
Atendemos pacientes de habla hispana.

PARTICIPATING IN ALZHEIMER'S RESEARCH: RESOURCE

Participating in Alzheimer's Research: For Yourself and Future Generations is a new 20-page booklet from NIH. It can help individuals decide if participating in clinical research is right for them, a friend, or a family member. At least 70,000 volunteers are now needed for more than 150 Alzheimer's and related clinical studies in the U.S. All kinds of people, including healthy older adults, can join in this research.

http://www.nia.nih.gov/alzheimers/publication/participating-alzheimers-research.


November 1, 2014

NATIONWIDE RECRUITMENT: BIPOLAR DISORDER ADULT RESEARCH STUDY
BIPOLAR DISORDER & RILUZOLE (OUTPATIENT OR INPATIENT: 8 WEEKS)

This study of Riluzole (an FDA-approved drug for Lou Gehrig's disease, ALS) tests how this drug affects glutamate in the brain and improves treatment-resistant depressive symptoms (failure to reduce symptoms after taking two or more antidepressants.) Recruiting ages 18-70. [03-M-0092]
This link is no longer valid.
National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services.
For more information on research conducted by the National Institute of Mental Health in Bethesda, MD click here www.nimh.nih.gov/JoinAStudy.

October 1, 2014

NATIONWIDE RECRUITMENT: BIPOLAR DISORDER (PEDIATRIC) RESEARCH STUDY
TREATMENT OF SEVERE MOOD DYSREGULATION, SMD (INPATIENT: 12- TO 15 WEEKS)

This study tests the efficacy of different treatments for decreasing irritability in children with severe mood and behavioral problems. Participants have symptoms of severe irritability and are not doing well on their current medications. The child must be currently in treatment with a physician, medically healthy and not currently hospitalized, psychotic, or suicidal. The study includes day or full hospitalization to discontinue medication, followed by either methylphenidate plus citalopram, or methylphenidate plus placebo. Recruiting ages 7-17. [09-M-0034]
http://www.nimh.nih.gov/labs-at-nimh/join-a-study/trials/childrens-studies/citalopram-methylphenidate-bpd.shtml
For more information on research conducted by the National Institute of Mental Health in Bethesda, MD click here www.nimh.nih.gov/JoinAStudy.

RETURN TO TOP

NIMH Updates

NIMH Update July 15, 2015

  • Boys more likely to have antipsychotics prescribed, regardless of age
  • NIH begins clinical trial of new medication for alcohol use disorder
  • SAMHSA's National Child Traumatic Stress Initiative helps children recover and thrive with new campaign
  • VA campaign encourages public to help raise PTSD awareness

NIMH Update June 15, 2015

  • Study may help Department of Veterans Affairs find patients with high risk of suicide
  • NIH study finds Alcohol Use Disorder on the increase
  • New report shows steady decline in underage drinking from 2002 to 2013
  • Opioid epidemic
  • High rates of sexual violence against children
  • New report shows increase in reported adverse health effects from synthetic cannabinoid use

NIMH Update June 1, 2015

  • A patient's budding cortex -- in a dish? Networking neurons thrive in 3-E human "organoid"
  • Animals' presence may ease social anxiety in kids with Autism
  • 4.3 million Americans working full-time had an anxiety disorder in the past year
  • Significant decreases in underage cigarette smoking seen in nearly every state from 2003 to 2013
  • SAMHSA reports highlight rise in Tramadol-related hospital ED visits

NIMH Update May 15, 2015

  • The NIMH Research Domain Criteria: The road to precision medicine starts here
  • GTEX findings reveal new insights into how DNA differences influence gene activity, disease susceptibility
  • May is Mental Health Awareness Month
  • Medication plus ongoing care provided in emergency departments is promising approach for opioid dependence

NIMH Update May 1, 2015

  • Souped-up remote control switches behaviors on-and-off in mice brain initiative yields chemical-genetic tool with push-pull capabilities
  • Brain circuitry for positive vs negative memories discovered in mice
  • A new look at racial/ethnic differences in mental health service use among adults
  • Time with parents is key for adolescents, study suggests
  • Nearly 1 in 10 full-time workers have had a substance use disorder in the past year
  • Expanding Naloxone use could reduce drug overdose deaths and save lives

NIMH Update April 15, 2015

  • CDC publishes first national study on use of behavioral therapy, medication, and dietary supplements for ADHD in children
  • NIH still active in Gulf region five years after oil spill
  • Study defines brain and behavioral effects of teen binge drinking
  • Study looks at effects of socioeconomic factors on child brain development and achievement
  • Access to health care improving among all racial and ethnic groups following Affordable Care Act
  • VA announces new grants to help end veteran homelessness

NIMH Update April 1, 2015

  • New NIMH strategic plan aims to focus, accelerate mental health research
  • NIH announces Follow That Cell Challenge finalists
  • HIV can spread early, evolve in patients' brains
  • NIH-funded study shows program for adults results in better school adjustment for children
  • Zuprexa Relprevv: drug safety communication
  • HHS takes strong steps to address opiod-drug related overdose, death and dependence
  • DEA issues nationwide alert on Fentanyl as threat to health and public safety

NIMH Update March 15, 2015

  • Pioneering NIMH data sharing
  • NIH-funded scientists identify brain site for stress role in binge alcohol drinking
  • Sensitive parenting may boost kids' later academic, relationship success
  • SAMHSA's suicide prevention mobile app to help health care providers save lives
  • HUD awards $150 million to provide permanent homes and services to extremely low-income persons with disabilities

NIMH Update March 1, 2015

  • Stillbirth may increase women's long-term risk for depression
  • Molecule hijacks enzyme to boost alcohol metabolism
  • HHS awards $386 million to support families through the Home Visiting Program
  • VA announces $300 million in grants to community partners working to end Veteran homelessness

NIMH Update February 15, 2015

  • The Clay Hunt Act: What the President just signed
  • FDA expands uses of Vyvanse to treat binge-eating disorder
  • Nationwide study reports shifts in Americans' use of natural products
  • SAMHSA is accepting applications for up to $13.6 million for Project LAUNCH Expansion grants

NIMH Update February 1, 2015

  • Disorders share risk gene pathways for immune, epigenetic regulation
  • Brain recalls old memories via new pathways
  • NIH launches tool to advance Down Syndrome research
  • NIH study reveals many Americans at risk for alcohol-medication interactions
  • SAMHSA's new report tracks the behavioral health of America
  • Affordable Care Act broadens insurance coverage for behavioral healthcare for young adults

NIMH Update January 15, 2015

  • Despite risks, benzodiazepine use highest in older people
  • Seeking single cells' secrets, NIH awards nearly $8 million in new grants
  • Teen prescription opioid abuse, cigarette, and alcohol use trends down
  • Combining benzodiazepines with other substances raises risks
  • FDA consumer advice on powdered pure caffeine

NIMH Update December 15, 2014

  • Soldiers at increased suicide risk after leaving hospital
  • Medications for patients with first-episode psychosis may not meet guidelines
  • Regulating a single gene may alter addiction and stress responses
  • NIH funds robots to assist people with disabilities
  • NIH updates Down Syndrome research plan
  • New HHS grants increase, improve learning opportunities for young children
  • FDA Drug Safety Communication: FDA reporting mental health drug Ziprasidone (Geodon) associated with rare but potentially fatal skin reactions

NIMH Update December 1, 2014

  • HHS and NIH take steps to enhance transparency of clinical trial results
  • Buprenorphine tapering less effective than ongoing maintenance for prescription opioid abuse
  • Nearly one in five adult Americans experienced mental illness in 2013
  • About 1 in 4 mental health treatment facilities offer services to quit smoking
  • Most people who drink excessively are not alcohol dependent
  • New tools simplify suicide prevention efforts

NIMH Update November 15, 2014

  • Soldiers at increased suicide risk after leaving hospital
  • Largest autism gene dragnet fingers 33 prime suspects
  • Renewed NIH centers focus on translation of aging research
  • New NIAAA resource gives guidance on treatment options for alcohol problems
  • NIDA researchers confirm important brain reward pathway
  • Federal officials announce new research on youth homelessness
  • Methylphenidate hydrochloride extended release tablets (generic concerta) made by Mallinckrodt and Kudco
  • HRSA awards $51.3 million in Affordable Care Act funding to support mental health and substance abuse treatment

NIMH Update November 1, 2014

  • Rapid agent restores pleasure-seeking ahead of other antidepressant action
  • NIMH creates new unit to support its research domain criteria initiative
  • Using social media to better understand, prevent, and treat substance use
  • Bullying of students with disabilities addressed in guidance to America's schools
  • Emergency department visits linked to "synthetic marijuana" products rising
  • SAMHSA and USDA team up to promote behavioral healthcare in communities across the U.S.
  • SAMHSA provides up to $743 million to promote youth mental and substance use disorder prevention programs

NIMH Update October 15, 2014

  • Increased health risks linked to first-episode psychosis
  • Groundbreaking suicide study
  • New report provides national clinical data on the prevalence of many specific mental disorders
  • HHS and DOJ award $3M to support innovative approaches to curb youth violence
  • SAMHSA provides up to $139 Million for integrated approaches to treat mental and substance use disorders
  • SAMHSA provides up to $231 Million to promote programs addressing children's mental health and substance use issues
  • SAMHSA provides up to $175 Million to promote treatment and recovery from mental and substance use disorders
  • SAMHSA provides up to $294 Million in tribal youth programs to prevent and treat mental and substance use disorders
  • New funding to support people with mental and substance use disorders
  • National Health Service Corps expands the primary care workforce in communities that need them most

NIMH Update October 1, 2014

  • Personalized screen to ID suicidal teens in 14 EDs
  • NIH awards initial $46 million for brain initiative research
  • NIH, VA address non-drug approaches to pain and related conditions in U.S. military personnel, veterans, and their families
  • NIH awards $35 million for centers for collaborative research in Fragile X
  • HHS announces $99 million in new grants to improve mental health services for young people
  • White House launces "it's on us" public awareness campaign to help prevent campus sexual assault
  • National survey shows lower rate of illicit drug use among adolescents ages 12 to 17
  • SAMHSA awards $936,000 in funding for the National Disaster Distress Helpline
  • Over $8 million in funding awarded to improve employment opportunities for people with disabilities
  • Justice Department announces $2.6 million in grants for domestic violence homicide prevention

RETURN TO TOP

NIMH Article Archives


Related Files

NIMH Update January 15, 2011 (PDF File)
NIMH Update February 1, 2011 (PDF File)
NIMH Update February 15, 2011 (PDF File)
NIMH Update March 1, 2011 (PDF File)
NIMH Update March 15, 2011 (PDF File)
NIMH Update April 1, 2011 (PDF File)
NIMH Update April 15, 2011 (PDF File)
NIMH Update May 1, 2011 (PDF File)
NIMH Update May 15, 2011 (PDF File)
NIMH Update June 1, 2011 (PDF File)
NIMH Update June 15, 2011 (PDF File)
NIMH Update July 1, 2011 (PDF File)
NIMH Update July 15, 2011 (PDF File)
NIMH Update August 1, 2011 (PDF File)
NIMH Update August 15, 2011 (PDF File)
NIMH Update September 1, 2011 (PDF File)
NIMH Update September 15, 2011 (PDF File)
NIMH Update October 1, 2011 (PDF File)
NIMH Update October 15, 2011 (PDF File)
NIMH Update November 1, 2011 (PDF File)
NIMH Update November 15, 2011 (PDF File)
NIMH Update December 1, 2011 (PDF File)
NIMH Update December 15, 2011 (PDF File)
NIMH Update January 15, 2012 (PDF File)
NIMH Update February 1, 2012 (PDF File)
NIMH Update February 15, 2012 (PDF File)
NIMH Update March 1, 2012 (PDF File)
NIMH Update March 15, 2012 (PDF File)
NIMH Update April 1, 2012 (PDF File)
NIMH Update April 15, 2012 (PDF File)
NIMH Update May 1, 2012 (PDF File)
NIMH Update May 15, 2012 (PDF File)
NIMH Update June 15, 2012 (PDF File)
NIMH Update July 1, 2012 (PDF File)
NIMH Update July 15, 2012 (PDF File)
NIMH Update August 1, 2012 (PDF File)
NIMH Update August 15, 2012 (PDF File)
NIMH Update September 1, 2012 (PDF File)
NIMH Update September 15, 2012 (PDF File)
NIMH Update October 1, 2012 (PDF File)
NIMH Update October 15, 2012 (PDF File)
NIMH Update November 1, 2012 (PDF File)
NIMH Update November 15, 2012 (PDF File)
NIMH Update December 1, 2012 (PDF File)
NIMH Update December 15, 2012 (PDF File)
NIMH Update January 15, 2013 (PDF File)
NIMH Update February 1, 2013 (PDF File)
NIMH Update February 15, 2013 (PDF File)
NIMH Update March 1, 2013 (PDF File)
NIMH Update April 1, 2013 (PDF File)
NIMH Update April 15, 2013 (PDF File)
NIMH Update May 1, 2013 (PDF File)
NIMH Update May 15, 2013 (PDF File)
NIMH Update June 1, 2013 (PDF File)
NIMH Update June 15, 2013 (PDF File)
NIMH Update July 1, 2013 (PDF File)
NIMH Update July 15, 2013 (PDF File)
NIMH Update August 1, 2013 (PDF File)
NIMH Update August 15, 2013 (PDF File)
NIMH Update September 1, 2013 (PDF File)
NIMH Update September 15, 2013 (PDF File)
NIMH Update October 1, 2013 (PDF File)
NIMH Update November 1, 2013 (PDF File)
NIMH Update November 15, 2013 (PDF File)
NIMH Update December 1, 2013 (PDF File)
NIMH Update December 15, 2013 (PDF File)
NIMH Update January 15, 2014 (PDF File)
NIMH Update February 1, 2014 (PDF File)
NIMH Update February 15, 2014 (PDF File)
NIMH Update March 1, 2014 (PDF File)
NIMH Update March 15, 2014 (PDF File)
NIMH Update April 15, 2014 (PDF File)
NIMH Update May 1, 2014 (PDF File)
NIMH Update May 15, 2014 (PDF File)
NIMH Update June 1, 2014 (PDF File)
NIMH Update June 15, 2014 (PDF File)
NIMH Update July 1, 2014 (PDF File)
2014 Smith Dinner Release
2014 Smith Dinner Release (PDF File)
NIMH Update July 15, 2014 (PDF File)
NIMH Update August 1, 2014 (PDF File)
NIMH Update August 15, 2014 (PDF File)
NIMH Update September 1, 2014 (PDF File)
NIMH Update September 15, 2014 (PDF File)
NIMH Update October 1, 2014 (PDF File)
NIMH Update October 15, 2014 (PDF File)
NIMH Update November 1, 2014 (PDF File)
NIMH Update November 15, 2014 (PDF File)
NIMH Update December 1, 2014 (PDF File)
NIMH Update December 15, 2015 (PDF File)
NIMH Update January 15, 2015 (PDF File)
NIMH Update February 1, 2015 (PDF File)
NIMH Update February 15, 2015 (PDF File)
NIMH Update March 1, 2015 (PDF File)
NIMH Update March 15, 2015 (PDF File)
NIMH Update April 1, 2015 (PDF File)
NIMH Depression Study Flyer (PDF File)
NIMH Update April 15, 2015 (PDF File)
NIMH Update May 1, 2015 (PDF File)
NIMH Update May 15, 2015 (PDF File)
NIMH Update June 1, 2015 (PDF File)
NIMH Update June 15, 2015 (PDF File)
NIMH Update July 1, 2015 (PDF File)

 | Print this page |